Pharmafile Logo
Pharmafocus logo
Advanced Search

Investments boost Irish pharma sector

March 11, 2010
Research and Development, Sales and Marketing Ireland, PPD, Warner Chilcott

Contract research organisation PPD has officially opened its new research laboratory in Athlone, Ireland, and started recruiting for the first …

News

German Health Minister attacks ‘pharma monopoly’

March 10, 2010
Sales and Marketing Germany, cost-effectiveness, price cuts, prices

German Health Minister Philipp Rösler wants to break pharma’s ‘monopolistic hold’ over the country by introducing price limits on new …

News

Five-year cardiovascular study planned for Onglyza

March 10, 2010
Research and Development, Sales and Marketing DPP-4, Onglyza, diabetes

Bristol-Myers Squibb and AstraZeneca are to embark on a five-year study of Onglyza in type II diabetes patients who may …

News

Abbott boosts pipeline with biotech acquisition

March 10, 2010
Research and Development, Sales and Marketing Abbott, Facet Biotech, daclizumab, volociximab

Abbott is to acquire US company Facet Biotech in a $450 million deal that will boost its oncology and immunology …

News
Worker protest

GSK Italy workers protest site closure

March 10, 2010
Research and Development GlaxoSmithKline, Italy, job cuts

Workers at a GlaxoSmithKline R&D facility in Verona, Italy, have taken to the streets to protest a decision to close …

News

Eusa Pharma appoints Iain McGill

March 10, 2010
Sales and Marketing Eusa Pharma, appointment, sales and marketing

Iain McGill has joined specialty company Eusa Pharma as international and European president. He moves to Eusa from Wyeth Pharmaceutical, …

Appointment

Pharma manufacturing news in brief

March 10, 2010
Manufacturing and Production Atacama Labs, Dishman, Excella, Mentor Worldwide, Next Pharma, SAFC Pharma, Stirling Products, Strides Arcolab, Watson Pharma, undefined

A round-up of pharma manufacturing developments from Strides Arcolab, Stirling Products, NextPharma, Atacama Labs, Excella, Dishman, SAFC Pharma, Watson Pharmaceutical …

News

Sanofi and Merck to merge animal health businesses

March 9, 2010
Sales and Marketing Merck, Sanofi, animal health

Sanofi-Aventis and Merck have announced a joint venture, bringing together their animal health businesses Merial and Intervet/Schering-Plough.  The company’s say …

News

Recentin disappoints in colorectal cancer

March 9, 2010
Research and Development AZ, Cancer, Recentin, colorectal cancer

AstraZeneca’s developmental oncology drug Recentin has failed to meet its primary endpoint in a phase II/III study. The once-daily oral …

News

Pfizer and King’s to collaborate on pain research

March 9, 2010
Research and Development King's, Pfizer, UK

Pfizer has partnered with King’s College London to create an open innovation laboratory for pain research.The project will include a …

News

Survey backs waiting room promotion, says IDS

March 9, 2010
Medical Communications disease awareness campaigns, patient information

A UK company specialising in promoting disease awareness messages to patients says a new study proves the value of its …

News

NHS funding boost for cancer diagnosis

March 8, 2010
Cancer, NHS, disease awareness campaigns

The government is to put £8 million into finding new ways of improving early cancer diagnosis for one or more …

News

Vidaza too costly for NICE

March 8, 2010
Sales and Marketing Celgene, NICE, Vidaza

NICE has rejected Celgene’s Vidaza for use on the NHS to treat the rare bone marrow disease myelodysplastic syndrome. The …

News
Rheumatoid arthritis

Roche halts ocrelizumab trials

March 8, 2010
Research and Development RoActemra, ocrelizumab, rheumatoid arthritis

The future of Roche and Biogen Idec’s rheumatoid arthritis drug ocrelizumab has been thrown into doubt after the manufacturers decided …

News
WileyCharlesYoung

Wiley-Blackwell appoints Dr Charles Young

March 8, 2010
Medical Communications Wiley, Wiley-Blackwell, appointment, medical communications

Dr Charles Young has joined Wiley-Blackwell as publishing director of global clinical solutions. He moves to the company from the …

Appointment

Ethex closed down after US court levies $27.6m in fines

March 8, 2010
Manufacturing and Production Ethex, KV Pharma, manufacturing and production

Generic drugmaker Ethex Corp has been fined $27.6 million by a US District Court after pleading guilty to two felony …

News

Orphan and rare disease marketers: are you armed for success?

March 8, 2010
Business Services, Sales and Marketing Orphan

Many marketers are currently unfamiliar with the specific approaches required in orphan and rare disease (ORD) brands, but will need …

Feature
Adventis Health

Adventis Health restructures

March 8, 2010
Medical Communications Adventis, medical communications

Adventis Health has restructured its client service teams in a move the coms agency says will allow it to better …

News
Pfizer Facebook

Digital Pharma: Byte-sized roundup

March 8, 2010
Medical Communications Pfizer, digital pharma, digital pharma pfizer

A roundup of digital developments, including Pfizer’s new Facebook page and beta-phase science blog, Lundbeck, BMS, Baxter and Janssen-Cilag on …

News

Stricter monitoring for UK supply chain

March 5, 2010
parallel trade, supply chain

New measures to ensure that the UK doesn’t suffer from shortages of prescription medicines have been announced by the government. …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025